Moreover, differential expression analysis of the data from GEO demonstrated that TFRC and SLC39A14 were highly expressed in NPC tissues, which was further confirmed by IHC experiments using clinical tissue samples. The gene discussed is TFRC; the disease is nasopharyngeal carcinoma.